Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors (Q61781157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Agnieszka Wozniak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Konrad Ptaszyński

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Maria Chosia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gabriel Olabiyi Ogun

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Janusz A Siedlecki

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

17

Markku Miettinen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

Jerzy Lasota

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

15

Wlodzimierz Ruka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

6

Wanda Michej

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

8

Piotr Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Anna Jerzak vel Dobosz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ewa Kraszewska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Maarit Sarlomo-Rikala

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sonja E Steigen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Regine Schneider-Stock

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jerzy Stachura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

16 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1029-1041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17632543%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700628

2 January 2020

exact match

0 references

cites work

Gastrointestinal stromal tumors: pathology and prognosis at different sites

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Regulation and targets of receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Biology of gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

C-kit gene mutation in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Mutations in gastrointestinal stromal tumors--a population-based study from Northern Norway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Multiple gastrointestinal stromal tumors with a germline c-kit mutation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

A new familial GIST identified

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021

KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700628

7 January 2021